InvestorsHub Logo

rtc110

03/31/20 5:04 PM

#259125 RE: amarininvestor #259122

I posted an article earlier today that seem to answer that question. The primary filer has 6 months protection from other generics. So if Hikma gets paid to delay then no one can be awarded an aNDA.

That was my layman's take so check my statement.

https://www.healthaffairs.org/do/10.1377/hpb20170721.583967/full/